• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Serum high-density lipoprotein (HDL) inhibits in vitro enterohemolysin (EHly) activity produced by enteropathogenic Escherichia coli.

作者信息

Figueirêdo Patricia M S, Catani Cleide F, Yano Tomomasa

机构信息

Departamento de Microbiologia e Imunologia, Instituto de Biologia, Universidade Estadual de Campinas, P.O. Box 6109, 13081-970, Campinas SP, Brazil.

出版信息

FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):53-7. doi: 10.1016/S0928-8244(03)00125-1.

DOI:10.1016/S0928-8244(03)00125-1
PMID:12900055
Abstract

Enterohemolysin (EHly) produced by Escherichia coli shows hemolytic activity towards washed erythrocytes from different animal species on blood agar plates. It has been shown recently that EHly activity is inhibited by normal mammalian serum and by cholesterol in vitro. Plasma lipoproteins can interact with bacterial toxins, such as endotoxin, to reduce their toxicity. In this work, we examine the ability of human purified chylomicrons, very low-density lipoproteins, intermediate-density, low-density and high-density lipoproteins, to inhibit the hemolytic activity of EHly. Our results show that these lipoproteins are hemolysin inactivators, and that high-density lipoprotein is the most potent inhibitor of enterohemolytic activity.

摘要

相似文献

1
Serum high-density lipoprotein (HDL) inhibits in vitro enterohemolysin (EHly) activity produced by enteropathogenic Escherichia coli.
FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):53-7. doi: 10.1016/S0928-8244(03)00125-1.
2
Thiol-independent activity of a cholesterol-binding enterohemolysin produced by enteropathogenic Escherichia coli.
Braz J Med Biol Res. 2003 Nov;36(11):1495-9. doi: 10.1590/s0100-879x2003001100008. Epub 2003 Oct 22.
3
Induction of apoptosis in Caco-2 and HT-29 human intestinal epithelial cells by enterohemolysin produced by classic enteropathogenic Escherichia coli.经典肠道致病性大肠杆菌产生的肠溶血素诱导Caco-2和HT-29人肠上皮细胞凋亡。
Lett Appl Microbiol. 2007 Oct;45(4):358-63. doi: 10.1111/j.1472-765X.2007.02154.x. Epub 2007 Sep 14.
4
Characterization and sequence of a 33-kDa enterohemolysin (Ehly 1)-associated protein in Escherichia coli.大肠杆菌中一种33 kDa肠溶血素(Ehly 1)相关蛋白的特性及序列分析
Gene. 1993 Sep 30;132(1):89-94. doi: 10.1016/0378-1119(93)90518-8.
5
Production and characterization of Escherichia coli enterohemolysin and its effects on the structure of erythrocyte membranes.大肠杆菌肠溶血素的产生、特性及其对红细胞膜结构的影响。
Cell Biol Int. 2002;26(2):175-86. doi: 10.1006/cbir.2001.0831.
6
Enterohemolysin, a new type of hemolysin produced by some strains of enteropathogenic E. coli (EPEC).肠溶血素,一种由某些肠道致病性大肠杆菌(EPEC)菌株产生的新型溶血素。
Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Mar;267(4):576-88. doi: 10.1016/s0176-6724(88)80042-7.
7
Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes.大肠杆菌溶血素通过使靶细胞膜通透化介导的强效杀白细胞作用。
J Exp Med. 1989 Mar 1;169(3):737-54. doi: 10.1084/jem.169.3.737.
8
In vitro leucocytotoxicity of alpha-hemolytic Escherichia coli.α-溶血性大肠杆菌的体外白细胞毒性
Dan Med Bull. 1993 Jun;40(3):295-305.
9
Plasma lipoproteins from patients with poorly controlled diabetes mellitus and "in vitro" glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B-containing lipoproteins.糖尿病控制不佳患者的血浆脂蛋白以及脂蛋白的“体外”糖化会提高胆固醇酯从高密度脂蛋白向含载脂蛋白B的脂蛋白的转移速率。
Diabetologia. 1997 Sep;40(9):1085-93. doi: 10.1007/s001250050791.
10
A peptide derived from the putative transmembrane domain in the tail region of E. coli toxin hemolysin E assembles in phospholipid membrane and exhibits lytic activity to human red blood cells: plausible implications in the toxic activity of the protein.一种源自大肠杆菌毒素溶血素E尾部区域假定跨膜结构域的肽在磷脂膜中组装,并对人红细胞表现出裂解活性:这对该蛋白质的毒性活性具有合理的启示。
Biochim Biophys Acta. 2009 Feb;1788(2):538-50. doi: 10.1016/j.bbamem.2008.11.013. Epub 2008 Nov 28.

引用本文的文献

1
pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles.肺炎溶血素和神经氨酸酶A可将高密度脂蛋白转化为促动脉粥样硬化颗粒。
iScience. 2021 May 12;24(6):102535. doi: 10.1016/j.isci.2021.102535. eCollection 2021 Jun 25.
2
HDL, Atherosclerosis, and Emerging Therapies.高密度脂蛋白、动脉粥样硬化与新兴疗法
Cholesterol. 2013;2013:891403. doi: 10.1155/2013/891403. Epub 2013 May 28.
3
Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond.
高密度脂蛋白的蛋白质组多样性:我们对其在脂质转运及其他方面重要性的新兴认识。
J Lipid Res. 2013 Oct;54(10):2575-85. doi: 10.1194/jlr.R035725. Epub 2013 Feb 24.
4
High density lipoprotein: it's not just about lipid transport anymore.高密度脂蛋白:它的功能不仅仅是脂质转运。
Trends Endocrinol Metab. 2011 Jan;22(1):9-15. doi: 10.1016/j.tem.2010.10.001. Epub 2010 Nov 8.